Real-world effectiveness and safety of vedolizumab induction therapy for Crohn's disease in Poland - a prospective, observational POLONEZ II study considering patients reported outcomes.

被引：0
|
作者：
Liebert, A. [1 ]
Klopocka, M. [1 ]
Cichoz-Lach, H. [2 ]
Michalak, A. [2 ]
Talar-Wojnarowska, R. [3 ]
Domzal-Magrowska, D. [3 ]
Filipiuk, A. [4 ]
Krogulecki, M. [4 ]
Kopertowska-Majchrzak, M. [5 ]
Eder, P. [6 ]
Stawczyk-Eder, K. [6 ]
Waszak, K. [6 ]
Zagorowicz, E. [7 ,8 ]
Wojciechowski, K. [9 ,10 ]
Drygala, S. [9 ]
机构：
[1] Nicolaus Copernicus Univ, Coll Medicum Bydgoszcz, Dept Gastroenterol & Nutr Disorders, Bydgoszcz, Poland
[2] Med Univ Lublin, Dept Gastroenterol, Lublin, Poland
[3] Med Univ Lodz, Dept Digest Tract Dis, Lodz, Poland
[4] Mil Inst Med, Dept Gastroenterol, Warsaw, Poland
[5] Gen Hosp, Dept Internal Dis, Miedzychod, Poland
[6] Poznan Univ Med Sci, H Swiecicki Univ Hosp, Dept Gastroenterol Dietet & Internal Dis, Poznan, Poland
[7] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Gastroenterol, Warsaw, Poland
[8] Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland
[9] Takeda Pharma Sp Zoo, Med Affairs, Warsaw, Poland
[10] Dept Internal Dis, Independent Publ Hlth Care Ctr, Tarczyn, Poland
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P421
引用
收藏
页码：550 / 551
页数：2
相关论文
共 50 条
  • [31] REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF IN BIOLOGIC-NAIVE CROHN'S DISEASE PATIENTS: RESULTS FROM THE EVOLVE STUDY
    Mantzaris, Gerassimos J.
    Yarur, Andres J.
    Silverberg, Mark S.
    Zezos, Petros
    Stein, Dara
    Kim, Hankyul
    Lissoos, Trevor
    Lopez, Claudia
    Natsios, Athanasios
    Radulescu, Gabriela
    Patel, Haridarshan
    Demuth, Dirk
    Bressler, Brian
    GASTROENTEROLOGY, 2019, 156 (06) : S638 - S638
  • [32] Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn’s disease in Europe: a retrospective observational study
    Roni Weisshof
    Stephan R. Vavricka
    Lieven Pouillon
    Fiona Braegger
    Montserrat Roset
    Nawal Bent-Ennakhil
    Marc Ferrante
    BMC Gastroenterology, 23
  • [33] Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn's disease in Europe: a retrospective observational study
    Weisshof, Roni
    Vavricka, Stephan R.
    Pouillon, Lieven
    Braegger, Fiona
    Roset, Montserrat
    Bent-Ennakhil, Nawal
    Ferrante, Marc
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [34] Real-World Safety and Effectiveness of Denosumab in Patients with Osteoporosis: A Prospective, Observational Study in South Korea
    Rhee, Yumie
    Chang, Dong-Gune
    Ha, Jeonghoon
    Kim, Sooa
    Lee, Yusun
    Jo, Euna
    Koh, Jung-Min
    ENDOCRINOLOGY AND METABOLISM, 2022, 37 (03) : 497 - 505
  • [35] Good efficacy and safety of vedolizumab in Crohn's disease and ulcerative colitis in a real-world scenario
    Zingone, Fabiana
    Barberio, Brigida
    Compostella, Federico
    Girardin, Giulia
    D'Inca, Renata
    Marinelli, Carla
    Marsilio, Ilaria
    Lorenzon, Greta
    Savarino, Edoardo Vincenzo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [36] Real-world treatment persistence with vedolizumab in Crohn's disease and ulcerative colitis patients
    Raluy, M.
    Fraeman, K.
    Donaldson, R.
    Reynolds, M.
    Smyth, M.
    Demuth, D.
    Khalid, J. M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S173 - S174
  • [37] Real-World Effectiveness of Vedolizumab as Induction Therapy in Inflammatory Bowel Disease: A Meta-Analysis
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Khalid, Javaria
    Loftus, Edward, Jr.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S24 - S24
  • [38] The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study
    Amiot, A.
    Grimaud, J. C.
    Treton, X.
    Filippi, J.
    Pariente, B.
    Peyrin-Biroulet, L.
    Noureille, A.
    Buisson, A.
    Carbonnel, F.
    Bourrier, A.
    Nancey, S.
    Roblin, X.
    Marteau, P.
    Altwegg, R.
    Moreau, J.
    Aubourg, A.
    Savoye, G.
    Pelletier, A. L.
    Fumery, M.
    Bonaz, B.
    Bouhnik, Y.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S313 - S314
  • [39] REAL-WORLD CLINICAL EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN BIOLOGIC-NAIVE PATIENTS WITH CROHN'S DISEASE BY DISEASE LOCATION: RESULTS FROM THE EVOLVE EXPANSION STUDY
    Scharl, Michael M.
    Christensen, Britt
    Bressler, Brian
    Brett, Neil R.
    Gianchetti, Lauren
    Kamble, Pravin
    Adsul, Shashi
    Farhat, Zeinab
    Ferrante, Marc
    GASTROENTEROLOGY, 2024, 166 (05) : S1422 - S1422
  • [40] PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB VERSUS VEDOLIZUMAB IN REAL-WORLD SETTINGS
    Chiorean, Michael V.
    Jiang, Jeanne
    Candela, Ninfa
    Chen, Grace
    Romdhani, Hela
    Latremouille-Viau, Dominick
    Shi, Sherry
    Bungay, Rebecca
    Fan, Tao
    GASTROENTEROLOGY, 2020, 158 (06) : S407 - S408
12345